GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Operating Margin %

Universal Ibogaine (TSXV:IBO) Operating Margin % : -80.82% (As of Apr. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Universal Ibogaine's Operating Income for the three months ended in Apr. 2024 was C$-0.43 Mil. Universal Ibogaine's Revenue for the three months ended in Apr. 2024 was C$0.54 Mil. Therefore, Universal Ibogaine's Operating Margin % for the quarter that ended in Apr. 2024 was -80.82%.

The historical rank and industry rank for Universal Ibogaine's Operating Margin % or its related term are showing as below:

TSXV:IBO' s Operating Margin % Range Over the Past 10 Years
Min: -443.14   Med: -321.14   Max: -34.86
Current: -34.86


TSXV:IBO's Operating Margin % is ranked better than
65.48% of 1011 companies
in the Biotechnology industry
Industry Median: -162.31 vs TSXV:IBO: -34.86

Universal Ibogaine's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Universal Ibogaine's Operating Income for the three months ended in Apr. 2024 was C$-0.43 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Apr. 2024 was C$-0.81 Mil.


Universal Ibogaine Operating Margin % Historical Data

The historical data trend for Universal Ibogaine's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Operating Margin % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Operating Margin %
Get a 7-Day Free Trial - - - -443.14 -199.13

Universal Ibogaine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -97.90 -5.36 -25.23 -31.58 -80.82

Competitive Comparison of Universal Ibogaine's Operating Margin %

For the Biotechnology subindustry, Universal Ibogaine's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Operating Margin % falls into.



Universal Ibogaine Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Universal Ibogaine's Operating Margin % for the fiscal year that ended in Jul. 2023 is calculated as

Operating Margin %=Operating Income (A: Jul. 2023 ) / Revenue (A: Jul. 2023 )
=-2.051 / 1.03
=-199.13 %

Universal Ibogaine's Operating Margin % for the quarter that ended in Apr. 2024 is calculated as

Operating Margin %=Operating Income (Q: Apr. 2024 ) / Revenue (Q: Apr. 2024 )
=-0.434 / 0.537
=-80.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Universal Ibogaine Operating Margin % Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine Business Description

Traded in Other Exchanges
Address
815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine Headlines